Bullboard Post History

by made2last

Order by:

V.TLT	RE:New Press Release - Theralase(R) Optimizes Phase II Bladder Cancer Clinical Study Hi all; Tthe powers that be surprised me by showing some mercy for the... October 23, 2023
V.TLT	RE:New Press Release - Theralase(R) Files US Patent for Enhanced Immunotherapy Hi all; This press release exudes confidence near term and into the future... October 5, 2023
V.TLT	RE:RE:RE:Points---- Hi Impalaman, The points expire after one year, and update upon your next... October 2, 2023
V.TLT	RE:New Press Release - Theralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM) Hi All; The cost savings, and the very low risk of a supply shortage of... September 29, 2023
V.TLT	RE:RE:RE:RE:RE:RE:and so we wait Langosta; I am so sorry to hear of your loss. I send you my condolences... September 10, 2023
V.TLT	RE:We are totally blowing Keytruda out of the water Hi all; Side effects of Tld-1433 Two simple treatments. Feeling... August 21, 2023
V.TLT	RE:RE:RE:RE:Total Shares vs Shares Out Hi all; After the recent PP, there should be about 221.3 million shares... August 18, 2023
V.TLT	RE:RE:New Cutting Edge Paper from Dr. McFarland and Colleagues Hi all; james700 wrote: Here's the question, will this advancement by... August 15, 2023
V.TLT	Sonodynamic Therapy Explained Hi All; Sonodynamic Therapy Explained https://en.m.wikipedia.org/wiki... July 18, 2023
V.TLT	RE:Transcript of Yesterday's Interview with Roger Hi all; When was this interview recorded? If this was live, I see two... July 7, 2023
V.TLT	Bashers and Weak Hands Hi all; A short quote to keep in mind! “Those who say it can’t be done... June 15, 2023
V.TLT	RE:RE:RE:Range of CR at 450 day mark Hi N0taP00p Your view of the math comparison is not quite right... April 5, 2023
V.TLT	RE:RE:RE:The CALM before the STORM---- Hi Impalaman; I have experienced the same thing too. However, I believe that... March 5, 2023
V.TLT	RE:Merck Will Hopefully Need Us enriquesuave, the world needs our technology. The gears moves slowly while... February 28, 2023
V.TLT	Data to be Presented at the AUA Annual Meeting Hi all; Theralase® Phase II NMIBC Clinical Study (Interim... February 2, 2023
V.TLT	News: Excerpt Hi All; News excerpt: Arkady Mandel MD, Ph.D., D.Sc., Interim Chief... January 25, 2023
V.TLT	Excellent Rebound Hi All; We must keep repeating, and make it very clear to those that are not... August 29, 2022
V.TLT	RE:RE:Theralase® Research - One of the Top 10 Most Downloaded Pape Hi wildbird1; Happy for an unexpected NR positive beginning on a Friday... June 24, 2022
V.TLT	Theralase® Research - One of the Top 10 Most Downloaded Pape Hi All; Very positive statement by our Interim CEO Dr... June 24, 2022
V.TLT	RE:Warrants to expire Hi All; I believe that these warrants had been extended two years ago, and I... May 11, 2022

Become a member today, It's free!

Bullboard Post History

by made2last

RE:New Press Release - Theralase(R) Optimizes Phase II Bladder Cancer Clinical Study

RE:New Press Release - Theralase(R) Files US Patent for Enhanced Immunotherapy

RE:RE:RE:Points----

RE:New Press Release - Theralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM)

RE:RE:RE:RE:RE:RE:and so we wait

RE:We are totally blowing Keytruda out of the water

RE:RE:RE:RE:Total Shares vs Shares Out

RE:RE:New Cutting Edge Paper from Dr. McFarland and Colleagues

Sonodynamic Therapy Explained

RE:Transcript of Yesterday's Interview with Roger

Bashers and Weak Hands

RE:RE:RE:Range of CR at 450 day mark

RE:RE:RE:The CALM before the STORM----

RE:Merck Will Hopefully Need Us

Data to be Presented at the AUA Annual Meeting

News: Excerpt

Excellent Rebound

RE:RE:Theralase® Research - One of the Top 10 Most Downloaded Pape

Theralase® Research - One of the Top 10 Most Downloaded Pape

RE:Warrants to expire

Featured Company

Majestic Gold Corp. V.MJS

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by made2last

Featured Company